BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17211286)

  • 1. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
    Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X; Whitworth CA; Rybak LP
    Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.
    Jie H; Tao S; Liu L; Xia L; Charko A; Yu Z; Bance M; Yin S; Robertson GS; Wang J
    Gene Ther; 2015 Jul; 22(7):546-52. PubMed ID: 25809464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
    Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
    Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
    Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Bungarotoxin application to the round window: an in vivo deafferentation model of the inner ear.
    Palmgren B; Jin Z; Ma H; Jiao Y; Olivius P
    Hear Res; 2010 Jun; 265(1-2):70-6. PubMed ID: 20184947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
    Fang B; Xiao H
    Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice.
    Schmitt NC; Rubel EW
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):614-20. PubMed ID: 23884286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
    García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R
    J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
    Bielefeld EC
    Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of inhibitor of apoptosis protein in gentamicin-induced cochlear hair cell damage.
    Tabuchi K; Pak K; Chavez E; Ryan AF
    Neuroscience; 2007 Oct; 149(1):213-22. PubMed ID: 17869439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin ototoxicity blocks sensory regeneration in the avian inner ear.
    Slattery EL; Warchol ME
    J Neurosci; 2010 Mar; 30(9):3473-81. PubMed ID: 20203207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-clarin-1 AAV-delivered ribozyme induced apoptosis in the mouse cochlea.
    Aarnisalo AA; Pietola L; Joensuu J; Isosomppi J; Aarnisalo P; Dinculescu A; Lewin AS; Flannery J; Hauswirth WW; Sankila EM; Jero J
    Hear Res; 2007 Aug; 230(1-2):9-16. PubMed ID: 17493778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity.
    Suzuki M; Yagi M; Brown JN; Miller AL; Miller JM; Raphael Y
    Gene Ther; 2000 Jun; 7(12):1046-54. PubMed ID: 10871754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function.
    Wang P; Zhang P; Huang J; Li M; Chen X
    Neurotoxicology; 2013 Jul; 37():51-62. PubMed ID: 23558232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.